SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

20 Jul 2024 Evaluate
A fair growth of 16.40% in the revenue at Rs. 3007.08 millions was reported in the June 2024 quarter as compared to Rs. 2583.42 millions during year-ago period.Net profit stood at Rs. 243.28  millions  compared to Rs. 215.57 millions in the corresponding previous quarter,high by 12.85%.Operating profit for the quarter ended June 2024 rose to 410.63 millions as compared to 364.73 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 3007.08 2583.42 16.40 3007.08 2583.42 16.40 12029.10 9751.72 23.35
Other Income 12.59 13.36 -5.76 12.59 13.36 -5.76 67.71 35.98 88.19
PBIDT 410.63 364.73 12.58 410.63 364.73 12.58 1680.25 1262.46 33.09
Interest 23.28 18.75 24.16 23.28 18.75 24.16 97.02 46.18 110.09
PBDT 387.35 345.98 11.96 387.35 345.98 11.96 1583.23 1216.28 30.17
Depreciation 60.63 55.10 10.04 60.63 55.10 10.04 241.89 259.83 -6.90
PBT 326.72 290.88 12.32 326.72 290.88 12.32 1341.34 956.45 40.24
TAX 83.44 75.31 10.80 83.44 75.31 10.80 344.89 242.55 42.19
Deferred Tax -1.81 -3.25 -44.31 -1.81 -3.25 -44.31 -16.70 -17.11 -2.40
PAT 243.28 215.57 12.85 243.28 215.57 12.85 996.45 713.90 39.58
Equity 110.49 110.31 0.16 110.49 110.31 0.16 110.49 110.31 0.16
PBIDTM(%) 13.66 14.12 -3.28 13.66 14.12 -3.28 13.97 12.95 7.90

Rossari Biotech Share Price

477.00 -1.75 (-0.37%)
04-May-2026 10:19 View Price Chart
Peers
Company Name CMP
BASF India 3711.80
Tata Chemicals 819.05
SRF 2533.20
Pidilite Inds. 1379.00
Deepak Nitrite 1731.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×